HEMATOLOGIC MALIGNANCIES (HM) Members of the Hematologic Malignancies Program (HM) are committed to advancing knowledge of the biologic basis of hematologic malignancies and exploiting this knowledge to reduce the morbidity and mortality caused by these disorders. The HM Program is led by Drs. Frederick R. Appelbaum and Geoffrey Hill, with Drs. Janice Abkowitz and Hans-Peter Kiem serving as Associate Leaders. The Program has four specific aims: (1) to develop and use emerging technologies to study the abnormalities that result in hematologic malignancies; (2) to better understand how normal blood stem cells function and how selected abnormalities might be corrected using gene therapy; and to develop improved treatments for hematologic malignancies using both non-transplant (Aim 3) and hematopoietic cell transplant-based (Aim 4) approaches. The HM Program currently has 113 members with 62 based at Fred Hutch, 42 based at University of Washington, and 9 based at Seattle Children?s. Since the prior cycle, HM has gained a net of 38 members. The current research support of HM members is $22.4M (direct costs), of which $11.8M is peer-reviewed funding, including $4.3M from the NCI. HM Program members published a total of 1,194 papers over the current grant period, of which 32% were intra-programmatic, 30% were inter-programmatic, and 53% had external co-authors. All 12 Consortium Shared Resources were utilized by HM members in the course of their work, with major contributions coming from Comparative Medicine, Therapeutic Manufacturing, Genomics & Bioinformatics, Research Pathology, Immune Monitoring & Flow Cytometry, and Biostatistics Shared Resources. This P30 grant also assists this program by providing administrative and logistical support for HM meetings, pilot funding for new research projects, and recruitment resources for new faculty.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Liu, Yanyan; Xiong, Sican; Sun, Wei et al. (2018) Joint Analysis of Strain and Parent-of-Origin Effects for Recombinant Inbred Intercrosses Generated from Multiparent Populations with the Collaborative Cross as an Example. G3 (Bethesda) 8:599-605
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746
Glaser, Adam K; Chen, Ye; Yin, Chengbo et al. (2018) Multidirectional digital scanned light-sheet microscopy enables uniform fluorescence excitation and contrast-enhanced imaging. Sci Rep 8:13878
Du, Jing; Flynn, Ryan; Paz, Katelyn et al. (2018) Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients. Blood 131:1743-1754
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
Shirts, Brian H; Konnick, Eric Q; Upham, Sarah et al. (2018) Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes. Am J Hum Genet 103:19-29
Kuzma, Jessica N; Hagman, Derek K; Cromer, Gail et al. (2018) Intra-individual variation in markers of intestinal permeability and adipose tissue inflammation in healthy normal weight to obese adults. Cancer Epidemiol Biomarkers Prev :

Showing the most recent 10 out of 1267 publications